DMAC
DiaMedica Therapeutics Inc.Company with tickers: DMAC
CIK
1401040
CUSIP
25253X207
Shares Outstanding
53,883,345
13F Activity (30d)
88 filings
87 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $7,987,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-10,482,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-10,042,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | — |